NanoViricides
NNVC
#10585
Rank
NZ$59.12 M
Marketcap
NZ$2.32
Share price
-0.76%
Change (1 day)
-7.29%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): NZ-$0.77

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$0.78. In 2025 the company made an earnings per share (EPS) of NZ-$1.12 an increase over its 2024 EPS that were of NZ-$1.25.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.77-31.79%
2025NZ-$1.12-10%
2024NZ-$1.25-5.41%
2023NZ-$1.325.71%
2022NZ-$1.25-13.58%
2021NZ-$1.44-66.11%
2020NZ-$4.261.7%
2019NZ-$4.19-10.98%
2018NZ-$4.70-22.35%
2017NZ-$6.06-10.53%
2016NZ-$6.77375%
2015NZ-$1.43-85.19%
2014NZ-$9.6242.11%
2013NZ-$6.7726.67%
2012NZ-$5.35-6.25%
2011NZ-$5.7014.28%
2010NZ-$4.99100%
2009NZ-$2.49-0%
2008NZ-$2.49-33.33%
2007NZ-$3.74-0%
2006NZ-$3.744445.07%
2005NZ-$0.08233

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ-$4.63 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.26-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.09-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.70-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ-$2.71 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.57 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA